Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection.

Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection.

Show other versions (1)

BACKGROUND: National and international guidelines call for the treatment of primary HIV infection (PHI) with combination antiretroviral therapy, although the ideal timing and duration of this intervention is unknown. Recent immunological studies of antiretroviral therapy on small numbers of patient...

Full description

Bibliographic Details
Main Authors:	Fidler, S, Oxenius, A, Brady, M, Clarke, J, Cropley, I, Babiker, A, Zhang, H, Price, D, Phillips, R, Weber, J
Format:	Journal article
Language:	English
Published:	2002

Similar Items

Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection.
by: Fidler, S, et al.
Published: (2002)

Short-course antiretroviral therapy in primary HIV infection.
by: Fidler, S, et al.
Published: (2013)

Highly active antiretroviral therapy interruption: predictors and virological and immunologic consequences.
by: Touloumi, G, et al.
Published: (2006)

Virological remission after antiretroviral therapy interruption in female African HIV seroconverters
by: Gossez, M, et al.
Published: (2018)

Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapy
by: Stöhr, W, et al.
Published: (2013)

Drug switching and virologic-based endpoints in trials of antiretroviral drugs for HIV infection.
by: Phillips, A, et al.
Published: (2004)

Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.
by: Prendergast, A, et al.
Published: (2008)

Virologic response to first-line efavirenz- or nevirapine-based antiretroviral therapy in HIV-infected African children
by: Kekitiinwa, A, et al.
Published: (2017)

Measures of site resourcing predict virologic suppression, immunologic response and HIV disease progression following highly active antiretroviral therapy (HAART) in the TREAT Asia HIV Observational Database (TAHOD)
by: Oyomopito, R., et al.
Published: (2010)

Variable fate of virus-specific CD4(+) T cells during primary HIV-1 infection.
by: Oxenius, A, et al.
Published: (2001)

Associations with virologic treatment failure in adults on antiretroviral therapy in South Africa.
by: Datay, M, et al.
Published: (2010)

Human immunodeficiency virus (HIV)-specific T helper responses fail to predict CD4+ T cell decline following short-course treatment at primary HIV-1 infection.
by: Fox, J, et al.
Published: (2008)

HIV-1 Virological Synapse is not Simply a Copycat of the Immunological Synapse.
by: Vasiliver-Shamis, G, et al.
Published: (2010)

The immunological and virological consequences of planned treatment interruptions in children with HIV infection
by: Klein, N, et al.
Published: (2013)

Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort.
by: Paris, D, et al.
Published: (1999)

How soon after HIV seroconversion is antiretroviral therapy initiated?
by: Babiker, A, et al.
Published: (1999)

Early antiretroviral therapy reduces hiv dna following perinatal HIV infection
by: Foster, C, et al.
Published: (2017)

HIV-1 DNA predicts disease progression and post-treatment virological control.
by: Williams, J, et al.
Published: (2014)

HIV virological non-suppression is highly prevalent among 18- to 24-year-old youths on antiretroviral therapy at the Kenyan coast
by: Nyongesa, MK, et al.
Published: (2022)

Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial
by: Szubert, A, et al.
Published: (2017)

Discordant outcomes following failure of antiretroviral therapy are associated with substantial differences in human immunodeficiency virus-specific cellular immunity.
by: Price, D, et al.
Published: (2003)

Virological blips and predictors of post treatment viral control after stopping ART started in primary HIV infection
by: Fidler, S, et al.
Published: (2017)

Distribution of functional HIV-specific CD8 T lymphocytes between blood and secondary lymphoid organs after 8-18 months of antiretroviral therapy in acutely infected patients.
by: Oxenius, A, et al.
Published: (2001)

Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial
by: Fidler, S, et al.
Published: (2020)

Determinants of restoration of CD4 and CD8 cell counts and their ratio in HIV-1 positive individuals with sustained virological suppression on antiretroviral therapy
by: Gras, L, et al.
Published: (2018)

Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load.
by: Oxenius, A, et al.
Published: (2002)

Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy.
by: Frater, A, et al.
Published: (2002)

Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes.
by: Oxenius, A, et al.
Published: (2000)

Socio-economic condition and lack of virological suppression among adults and adolescents receiving antiretroviral therapy in Ethiopia
by: Plymoth, M, et al.
Published: (2020)

HIV-1 drug resistance in primary infections in the UK.
by: Fidler, S, et al.
Published: (2001)

Slower CD4 cell decline following cessation of a 3 month course of HAART in primary HIV infection: findings from an observational cohort.
by: Fidler, S, et al.
Published: (2007)

British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2015
by: Churchill, D, et al.
Published: (2016)

A randomised controlled trial comparing the impact of Antiretroviral Therapy (ART) with a ‘Kick-and-Kill’ approach to ART alone on HIV reservoirs in individuals with primary HIV infection (PHI); RIVER trial
by: Fidler, S, et al.
Published: (2018)

HIV-1 protease as a target for antiretroviral therapy
by: Windsor, Ian William.
Published: (2019)

Universal voluntary HIV testing and immediate antiretroviral therapy.
by: Jaffe, H, et al.
Published: (2009)

Enhanced prophylaxis with antiretroviral therapy for advanced HIV in Africa
by: Hakim, J, et al.
Published: (2017)

The moral and fiscal implications of antiretroviral therapies for HIV in Africa
by: Collier, P, et al.
Published: (2018)

When to start antiretroviral therapy in HIV-associated tuberculosis.
by: Török, M, et al.
Published: (2011)

Monitoring of highly active antiretroviral therapy in HIV infection.
by: Walker, A, et al.
Published: (2011)

Virological and immunological correlates of mother-to-child transmission of cytomegalovirus in The Gambia.
by: Kaye, S, et al.
Published: (2008)